Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099655 · ClinicalTrials.gov registry record · NA
Attain Stability™ Quad Clinical Study
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 471
- Enrollment target
NCT03099655 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 471 participants.
The verdict
NCT03099655, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 471 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate the safety and efficacy of the Attain Stability Quadripolar MRI SureScan Left Ventricular (LV) lead (Model 4798).
Interventions
- DEVICE Attain Stability Quad Left Ventricular Pacing Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2017-07-07 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03099655
The ClinicalTrials.gov registry entry for NCT03099655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Attain Stability Quad Left Ventricular Pacing Lead is the first listed.
NCT03099655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03099655 about?
NCT03099655 is a clinical study titled "Attain Stability™ Quad Clinical Study". The purpose of this clinical study is to evaluate the safety and efficacy of the Attain Stability Quadripolar MRI SureScan Left Ventricular (LV) lead (Model 4798).
What is the current status of trial NCT03099655?
This trial is currently completed. It is a NA study. The enrollment target is 471 participants. The study started on 2017-07-07. Estimated completion is 2019-05-31.
What interventions are being tested in trial NCT03099655?
The interventions under investigation include: Attain Stability Quad Left Ventricular Pacing Lead (DEVICE).
Who is sponsoring clinical trial NCT03099655?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.